Legal Archives - Boston Life Sciences Times

Capital Discipline Matters: Sam Zell’s Lessons for Every Entrepreneur

December 13, 2025

Kymera Therapeutics Closes Upsized $602 Million Public Offering, Underwriters Fully Exercise Option

December 12, 2025

Prilenia and Ferrer gain FDA approval to launch Phase 3 ALS study of pridopidine

December 11, 2025

THIS WEEK'S STORIES

Phare Bio and Basilea form partnership to develop AI-designed broad-spectrum antibiotic

December 11, 2025

Thermo Fisher Scientific Expands Gibco Bacto Portfolio With Next-Generation Chemically Defined Media

December 15, 2025

Ankyra Appoints Sailaja Battula, PhD, as Chief Scientific Officer

December 15, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Legal

NeoGenomics Says Natera Withdraws Appeal in RaDaR Patent Litigation

Earned Expands Services with Addition of Dental & Medical Counsel, Bringing Specialized Legal Support for Healthcare Professionals

Enveric Biosciences Retains Fish & Richardson to Defend U.S. Patent Linked to Bretisilocin Following AbbVie’s $1.2 Billion Acquisition

Los Angeles Jury Awards Nearly $1 Billion Against Johnson & Johnson in Mesothelioma Talc Case

Boston Jury Awards $83 Million in Asbestos Verdict Against American Art Clay Company

Most Read

Linus Health appoints Julie Wood, MD, MPH, FAAFP, as senior medical director for clinician engagement

Fondazione Telethon, Orphan Therapeutics Accelerator outline non-profit pathway for U.S. access to ultra-rare gene therapy

Sōlaria Biō study links gut barrier health, inflammation and bone density in breakthrough findings

DexCare Appoints Rakshay Jain as Chief Product Officer to Advance Patient Navigation Platform

EDITOR PICKS